Oxford Endovascular Limited
Oxford Endovascular Limited
Trading as: Oxford Endovascular
#09769779 • Active
B2bManufacturingPhysical Product
Oxford Endovascular Ltd is a pioneering medical device company focused on preventing brain hemorrhage by treating brain aneurysms. Their innovative OxiFlow™️ flow-diverter technology offers a safer and more accurate solution for patients at risk of aneurysm rupture.
Founded: 09/09/2015
Industries: Research and experimental development on biotechnology
Website: https://oxfordendovascular.com
Email: Subscribe to view
Location: Oxford
Products
- Oxiflow™️ Flow-diverter
Financial Snapshot
Last accounts made up to 30 September 2023
Next accounts due 30 June 2025 (1 month)
Cash in Bank £2.8m
↓ -47%
Total Liabilities £0.96m
↓ -17%
Employees 7
↑ 0%
Directors
Name | Role | Appointed ↓ | Nationality | Age |
|---|---|---|---|---|
| Martin Henry Diggle | Investor | 19/02/2021 | British | 63 years |
| Charles Richard Taylor | Director | 01/01/2020 | British | 66 years |
| Xie Feng | Director | 23/12/2015 | Chinese | 40 years |
| James Vincent Byrne | Professor | 23/12/2015 | British | 74 years |
Role:
Investor
Appointed:
19/02/2021
Nationality:
British
Age:
63 years
Role:
Director
Appointed:
01/01/2020
Nationality:
British
Age:
66 years
Role:
Director
Appointed:
23/12/2015
Nationality:
Chinese
Age:
40 years
Role:
Professor
Appointed:
23/12/2015
Nationality:
British
Age:
74 years
People with Significant Control
| Name | Nature of Control | Notified On | Nationality |
|---|---|---|---|
| Parkwalk Advisors Ltd | Voting Rights 25 To 50 Percent | 09/04/2024 | United Kingdom |
Nature of Control:
Voting Rights 25 To 50 Percent
Notified On:
09/04/2024
Nationality:
United Kingdom
Financial Accounts
| Sep 2023 | Sep 2022 | Sep 2021 | |
|---|---|---|---|
| Income Statement | |||
| Turnover | |||
| Export Revenue | |||
| Sales | |||
| Other Operating Income | |||
| Other Operating Items | |||
| Cost of Sales | |||
| Raw Materials & Consumables | |||
| Gross Profit | |||
| Admin Expenses | |||
| Other Operating Charges | |||
| Depreciation | |||
| R&D Expenses | |||
| Operating Profit | |||
| EBITDA | |||
| Financial Revenue | |||
| Financial Expenses | |||
| Financial Profit/Loss | |||
| Interest Paid | |||
| Extraordinary Revenue | |||
| Extraordinary Expenses | |||
| Net Extraordinary Items | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Retained Profit | |||
| Balance Sheet | |||
| Non-Current Assets | |||
| Intangible Assets | |||
| Tangible Fixed Assets | |||
| Other Non-Current Assets | |||
| Current Assets | |||
| Stock | |||
| Debtors | |||
| Cash in Hand | |||
| Other Current Assets | |||
| Called Up Share Capital | |||
| P&L Account Reserve | |||
| Shareholder Funds | |||
| Other Shareholder Funds | |||
| Provisions | |||
| Long Term Debt | |||
| Creditors (> 1 year) | |||
| Other Non-Current Liabilities | |||
| Short Term Debt | |||
| Creditors | |||
| Creditors (< 1 year) | |||
| Other Current Liabilities | |||
| Key Metrics | |||
| Net Assets | |||
| Net Current Assets | |||
| Total Assets Less Current Liabilities | |||
| Working Capital | |||
| Enterprise Value | |||
| Added Value | |||
| Cashflow Before D&A | |||
| Other Information | |||
| Staff Costs | |||
| Number of Employees | |||
Charges
No charges registered
Properties
No property information available
Grants
Total grant funding received: £349,998.60
| Programme | |||
|---|---|---|---|
| 01/11/2020 | £349,998.60 | Department for Business, Energy and Industrial Strategy | ALB - UKRI - Innovate UK grant awards in 20-21 |
| Full Grant details (including summaries) can be found on the Gateway to Research website: https://gtr.ukri.org/projects?ref=71494 | |||
Department for Business, Energy and Industrial Strategy
£349,998.60Full Grant details (including summaries) can be found on the Gateway to Research website: https://gtr.ukri.org/projects?ref=71494
Date Awarded:
01/11/2020
Programme:
ALB - UKRI - Innovate UK grant awards in 20-21
Government Council Contracts Beta
No council contracts found
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 06/01/2025 | Capital | Capital Allotment Shares | View (3 pages) |
| 04/10/2024 | Officers | Termination Director Company With Name Termination Date | View (1 page) |
| 16/09/2024 | Officers | Change Person Director Company With Change Date | View (2 pages) |
| 16/09/2024 | Confirmation Statement | Confirmation Statement With Updates | View (6 pages) |
| 25/06/2024 | Accounts | Accounts With Accounts Type Small | View (12 pages) |
| 11/06/2024 | Officers | Change Corporate Director Company With Change Date | View (1 page) |
| 01/05/2024 | Incorporation | Memorandum Articles | View (30 pages) |